Search Browse Earnings

Cryoport, Inc. — SlamSEC

Cryoport, Inc.

Nasdaq:CYRX

Pharmaceutical Preparations·BRENTWOOD, TN

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$168.7M

-28.9% YoY

FY 2025

Adj. EBITDA

-$73.0M

-43.3% margin

FY 2025

Net Income

-$99.6M

-59.0% margin

FY 2025

EPS (Diluted)

-$2.21

FY 2025

Stock Price

$7.96

-4.8%

2026-03-09

52W Range

$4.63 – $11.45

P/E Ratio

-3.6x

Market Cap

$396.6M

Cash

$29.2M

FY 2025

Total Debt

$468,325

FY 2012

Net Cash

$28.8M

FY 2012

Enterprise Value

$367.8M

Debt / EBITDA

0.4x

FY 2025

EV / EBITDA

-5.0x

Employees

1K

FY 2025

CEO

Shelton Jerrell

CFO

Stefanovich Robert